Ganesh Benzoplast
GANESHBE · Chemicals > Chemicals · Chairman: Rishi Ramesh Pilani · MD: Rishi Ramesh Pilani · Listing date: Dec. 28, 1994

Stock Price vs Company Growth
1d
0.3%
1w
1.0%
1m
6.5%
3m
5.1%
6m
18.9%
1y
27.0%
all
4.7%
Created with Highcharts 8.2.2SalesProfitPriceDividendQtr SalesOperating CashflowSep07Mar11Sep14Mar18Sep21Latest

Use @ for users, # for companies and : for emojis
 
 
 
 
Last Traded Price

112 0.3%
102
134
Company Overview

Sales
374 Cr
Growth: -6.5%
Profit after Tax
38.1 Cr
Growth: -41.9%
Small Cap
806 Cr
P/E: 21.2x
Industry P/E: 29.9x
Created with Highcharts 8.2.2HistoricalGrowthValuationAttractivenessProfitabilityIndustryOutlookPriceStability10
Fundamentals

Sales (Cr) ₹ 374
Growth -6.5%
EBITDA 28.9%
P/S 2.2x
Dividend 0.0%
P/E 21.2x
Book Value ₹ 74.8
PEG Ratio -3.3x
ROE 7.1%
P/B 1.5x
Shareholding Pattern

Institutions
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Promoters
Susram Financial Services & Realty Pvt.Ltd
16.93 %
Ganesh Risk Management Pvt.Ltd
7.97 %
Sushila Ramesh Pilani
5.59 %
Tarang Advisory Pvt. Ltd.
4.81 %
Rishi Ramesh Pilani
2.55 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Others
Stolt-Nielsen Singapore Pte Ltd.
9.8 %
Anil Vishanji Dedhia
4.7 %
Nishant Kailash Agarwal
2.56 %
Dalapatraj P Jain
1.32 %
Nidhi Jawahar
1.02 %
Created with Highcharts 8.2.2Mar20Jun20Sep20Dec20Mar21Jun22Sep22Dec22Mar23
Increase    Decrease    No change
Company Profile Detailed

:The company is engaged in the manufacturing and exporting of drug intermediates, pharmaceutical intermediates, bulk drug intermediates, food preservatives, lubricants, API/bulk drug, etc.
Investors (25)
Followers (2)